These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 24999574)

  • 1. Non-invasive fibrosis tests are correlated with necroinflammatory actvity of liver in patients with chronic hepatitis B.
    Ozyalvacli G; Kucukbayrak A; Kurt M; Gurel K; Gunes O; Ustun C; Akdeniz H
    Clin Ter; 2014; 165(3):e199-204. PubMed ID: 24999574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The diagnostic value of non-invasive tests for the evaluation of liver fibrosis in chronic hepatitis B patients.
    Erdogan S; Dogan HO; Sezer S; Uysal S; Ozhamam E; Kayacetin S; Koca Y
    Scand J Clin Lab Invest; 2013; 73(4):300-8. PubMed ID: 23514016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The PAPAS index: a novel index for the prediction of hepatitis C-related fibrosis.
    Ozel BD; Poyrazoğlu OK; Karaman A; Karaman H; Altinkaya E; Sevinç E; Zararsiz G
    Eur J Gastroenterol Hepatol; 2015 Aug; 27(8):895-900. PubMed ID: 25951491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Value of non-invasive models of liver fibrosis in judgment of treatment timing in chronic hepatitis B patients with ALT < 2×upper limit of normal].
    Zhou QQ; Hu YB; Zhou K; Zhang WW; Li MH; Dong P; Di JG; Hong L; Du QW; Xie Y; Sun QF
    Zhonghua Gan Zang Bing Za Zhi; 2016 Sep; 24(9):665-670. PubMed ID: 27788722
    [No Abstract]   [Full Text] [Related]  

  • 5. The predictive value of noninvasive serum markers of liver fibrosis in patients with chronic hepatitis C.
    Gökcan H; Kuzu UB; Öztaş E; Saygılı F; Öztuna D; Suna N; Tenlik İ; Akdoğan M; Kaçar S; Kılıç ZM; Kayaçetin E
    Turk J Gastroenterol; 2016 Mar; 27(2):156-64. PubMed ID: 26853790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The diagnostic value of a globulin/platelet model for evaluating liver fibrosis in chronic hepatitis B patients.
    Coskun BD; Altinkaya E; Sevinc E; Ozen M; Karaman H; Karaman A; Poyrazoglu O
    Rev Esp Enferm Dig; 2015 Dec; 107(12):740-4. PubMed ID: 26671586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Noninvasive assessment of hepatic fibrosis in Egyptian patients with chronic hepatitis C virus infection.
    Fouad SA; Esmat S; Omran D; Rashid L; Kobaisi MH
    World J Gastroenterol; 2012 Jun; 18(23):2988-94. PubMed ID: 22736923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of AST to platelet ratio index in the detection of liver fibrosis in patients with recurrent hepatitis C after liver transplantation.
    Toniutto P; Fabris C; Bitetto D; Falleti E; Avellini C; Rossi E; Smirne C; Minisini R; Pirisi M
    J Gastroenterol Hepatol; 2007 Nov; 22(11):1904-8. PubMed ID: 17914968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibro-α score as a simple and useful non-invasive test for predicting significant liver fibrosis in chronic hepatitis C patients.
    Omran MM; Farid K; Emran TM; Attallah AA
    Arab J Gastroenterol; 2011 Jun; 12(2):74-9. PubMed ID: 21684477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Correlation of liver stiffness measured by FibroTouch and FibroScan with Ishak fibrosis score in patients with chronic hepatitis B].
    Chen GF; Ping J; Gu HT; Zhao ZM; Zhou Y; Xing F; Tao YY; Mu YP; Liu P; Liu CH
    Zhonghua Gan Zang Bing Za Zhi; 2017 Feb; 25(2):145-150. PubMed ID: 28297803
    [No Abstract]   [Full Text] [Related]  

  • 11. Aspartate aminotransferase-to-platelet ratio index for fibrosis and cirrhosis prediction in chronic hepatitis C patients.
    Silva RG; Fakhouri R; Nascimento TV; Santos IM; Barbosa LM
    Braz J Infect Dis; 2008 Feb; 12(1):15-9. PubMed ID: 18553008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FibroScan, APRI, FIB4, and GUCI: Role in prediction of fibrosis and response to therapy in Egyptian patients with HCV infection.
    Yosry A; Fouad R; Alem SA; Elsharkawy A; El-Sayed M; Asem N; Hassan E; Ismail A; Esmat G
    Arab J Gastroenterol; 2016 Jun; 17(2):78-83. PubMed ID: 27353055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel non-invasive score for the prediction of advanced fibrosis in patients with chronic hepatitis B.
    Okdemir S; Cakmak E
    Ann Hepatol; 2022; 27(1):100544. PubMed ID: 34571267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AST/ALT ratio is not useful in predicting the degree of fibrosis in chronic viral hepatitis patients.
    Eminler AT; Ayyildiz T; Irak K; Kiyici M; Gurel S; Dolar E; Gulten M; Nak SG
    Eur J Gastroenterol Hepatol; 2015 Dec; 27(12):1361-6. PubMed ID: 26352130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is there any non-invasive marker replace the needle liver biopsy predictive for liver fibrosis, in patients with chronic hepatitis?
    Vardar R; Vardar E; Demiri S; Sayhan SE; Bayol U; Yildiz C; Postaci H
    Hepatogastroenterology; 2009; 56(94-95):1459-65. PubMed ID: 19950810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic accuracy of different noninvasive scores for detecting advanced fibrosis in chronic hepatitis B.
    Hamidi AA; Oncul A; Ozguven BY; Sevgi DY; Gunduz A; Uzun N; Dokmetas I
    Eur J Gastroenterol Hepatol; 2019 Nov; 31(11):1439-1443. PubMed ID: 31033847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibro-Mark: a panel of laboratory parameters for predicting significant fibrosis in chronic hepatitis C patients.
    Attallah AM; Omran D; Omran MM; Albannan MS; Zayed RA; Saif S; Farid A; Hassany M; Yosry A
    Br J Biomed Sci; 2018 Jan; 75(1):19-23. PubMed ID: 28945150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-invasive fibrosis markers for assessment of liver fibrosis in chronic hepatitis delta.
    Kalkan Ç; Yılmaz Y; Erdoğan BD; Savaş B; Yurdcu E; Çalışkan A; Keskin O; Gencdal G; Zeybel M; Törüner M; Bozdayi AM; Idilman R; Yurdaydin C
    J Viral Hepat; 2023 May; 30(5):406-416. PubMed ID: 36651603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical usefulness of mean platelet volume and red blood cell distribution width to platelet ratio for predicting the severity of hepatic fibrosis in chronic hepatitis B virus patients.
    Karagoz E; Ulcay A; Tanoglu A; Kara M; Turhan V; Erdem H; Oncul O; Gorenek L
    Eur J Gastroenterol Hepatol; 2014 Dec; 26(12):1320-4. PubMed ID: 25210777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison and validation of simple noninvasive tests for prediction of fibrosis in chronic hepatitis C.
    Lackner C; Struber G; Liegl B; Leibl S; Ofner P; Bankuti C; Bauer B; Stauber RE
    Hepatology; 2005 Jun; 41(6):1376-82. PubMed ID: 15915455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.